type of digital currency Knowledge graph

Shanghai's announcement of the action plan for mergers and acquisitions of listed companies is indeed a heavy news. However, can this still retain the retail investors who were hurt by the market on Tuesday? On Tuesday, A shares opened higher and fell back, which triggered a crisis of confidence in the market to some extent. So, shall we go or stay? Let me express my personal views.Third, cultivate about 10 internationally competitive listed companies in the field;First, the plan mentioned that by 2027, we will strive to land a number of representative M&A cases in key industries, form a M&A transaction scale of 300 billion yuan, and activate total assets of over 2 trillion yuan;

It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.Second, the key areas mainly involve integrated circuits, biomedicine, new materials and other industries. Make good use of the 10 billion yuan integrated circuit design industry M&A fund and set up a 10 billion yuan biomedical industry M&A fund;

Just when everyone was still sick, A-shares ushered in good news. Shanghai issued the "Shanghai Action Plan to Support the Merger and Reorganization of Listed Companies (2025-2027)". Is this to retain injured retail investors? Next, let's discuss it in detail.Second, the key areas mainly involve integrated circuits, biomedicine, new materials and other industries. Make good use of the 10 billion yuan integrated circuit design industry M&A fund and set up a 10 billion yuan biomedical industry M&A fund;